loading page

Successful Treatment of a Keratoacanthoma in a Young Patient with the Application of Topical 5% Imiquimod Cream
  • +7
  • Kerasia-Maria Plachouri,
  • Francesk Mulita,
  • Levan Tchabashvili,
  • Elias Liolis,
  • Charalampos Kaplanis,
  • Ioannis Perdikaris,
  • Fotis Iliopoulos,
  • Georgios-Ioannis Verras,
  • Vasilios Tolias,
  • Sophia Georgiou
Kerasia-Maria Plachouri
University General Hospital of Patras Holy Mary the Help

Corresponding Author:[email protected]

Author Profile
Francesk Mulita
University General Hospital of Patras Holy Mary the Help
Author Profile
Levan Tchabashvili
University General Hospital of Patras Holy Mary the Help
Author Profile
Elias Liolis
University General Hospital of Patras Holy Mary the Help
Author Profile
Charalampos Kaplanis
University General Hospital of Patras Holy Mary the Help
Author Profile
Ioannis Perdikaris
University General Hospital of Patras Holy Mary the Help
Author Profile
Fotis Iliopoulos
University General Hospital of Patras Holy Mary the Help
Author Profile
Georgios-Ioannis Verras
University General Hospital of Patras Holy Mary the Help
Author Profile
Vasilios Tolias
University General Hospital of Patras Holy Mary the Help
Author Profile
Sophia Georgiou
University General Hospital of Patras Holy Mary the Help
Author Profile

Abstract

Keratoacanthomas (KA) are epithelial tumors that present as rapidly evolving nodules with a central hyperkeratotic plug, and occasionally show signs of spontaneous regression. A 21-years-old patient strongly refused the diagnostic biopsy and insisted on a non surgical treatment. He was successfully treated with imiquimod 5% cream.
09 Aug 2021Submitted to Clinical Case Reports
11 Aug 2021Submission Checks Completed
11 Aug 2021Assigned to Editor
23 Aug 2021Reviewer(s) Assigned
24 Aug 2021Review(s) Completed, Editorial Evaluation Pending
30 Aug 2021Editorial Decision: Revise Minor
31 Aug 20211st Revision Received
01 Sep 2021Submission Checks Completed
01 Sep 2021Assigned to Editor
01 Sep 2021Review(s) Completed, Editorial Evaluation Pending
25 Sep 2021Editorial Decision: Accept
Nov 2021Published in Clinical Case Reports volume 9 issue 11. 10.1002/ccr3.4920